Wende Hutton joined Canaan Partners in 2004 as a Venture Partner in the healthcare sector focusing on medical devices and biotechnology. While at Canaan, Wende has played an instrumental role in the sales and marketing and recruiting strategies for many healthcare clients including Alsius, Northstar Neuroscience and ReVision Optics.Prior to Canaan Partners, Wende was a General Partner of Spring Ridge Ventures from 2001 to 2003, where her investments included Northstar Neuroscience and Spine Wave. Her venture career began at Mayfield Fund in 1993 in the Health Care Technology Group. She served as a General Partner at Mayfield from 1995 to 2001. During her tenure at Mayfield, Wende incubated Heartstream, Inc. (NASDAQ: HPQ) and Northstar Neuroscience, working closely with those founding teams. Prior to Mayfield, Wende held management positions at Nellcor, Inc. and GenPharm International in business development and marketing. Wende sits or has served on the boards of Micro Therapeutics, Inc. (NASDAQ: EVVV), Orquest (NASDAQ: JNJ), Heartstream, Inc. (NASDAQ:HPQ), Alsius, Inc., SenoRx, Northstar Neuroscience, ReVisionOptics, Aperon Biosciences and Oculir, Inc. Wende holds an AB in Human Biology from Stanford University and a MBA from Harvard Business School where she was a Baker Scholar.